Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

The ability to discriminate between Alzheimer’s disease (AD), subcortical vascular disease, and other cognitive disorders is crucial for diagnostic purposes and clinical trial outcomes. Patients with primarily subcortical vascular disease are unlikely to benefit from treatments targeting the AD path...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Cereb Blood Flow Metab
Κύριοι συγγραφείς: Wallin, Anders, Nordlund, Arto, Jonsson, Michael, Blennow, Kaj, Zetterberg, Henrik, Öhrfelt, Annika, Stålhammar, Jacob, Eckerström, Marie, Carlsson, Mårten, Olsson, Erik, Göthlin, Mattias, Svensson, Johan, Rolstad, Sindre, Eckerström, Carl, Bjerke, Maria
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2016
Θέματα:
Review Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702291/
https://ncbi.nlm.nih.gov/pubmed/26219595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.148
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια